(Q36138347)

12 August 2017

1 reference

title

Measuring the value of pharmacogenomics (English)

1 reference

12 August 2017

1 reference

Kathryn A Phillips

1

1 reference

PubMed ID

15915153

12 August 2017

Stephanie L Van Bebber

series ordinal

2

1 reference

12 August 2017

1 June 2005

1 reference

Nature Reviews Drug Discovery

12 August 2017

1 reference

12 August 2017

4

1 reference

12 August 2017

6

1 reference

12 August 2017

500-509

1 reference

https://scigraph.springernature.com/pub.10.1038/nrd1749

12 August 2017

0 references

cites work

Shattuck lecture--medical and societal consequences of the Human Genome Project.

1 reference

Implications of the Human Genome Project for medical science.

21 January 2018

1 reference

Population screening in the age of genomic medicine

21 January 2018

1 reference

An introduction to cost-effectiveness and cost–benefit analysis of pharmacogenomics

21 January 2018

1 reference

Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review

21 January 2018

1 reference

The economics of gene therapy and of pharmacogenetics

21 January 2018

1 reference

Pharmacogenetics and the practice of medicine

21 January 2018

1 reference

Pharmacogenetics: an opportunity for a safer and more efficient pharmacotherapy

21 January 2018

1 reference

Genetic testing for enzymes of drug metabolism: does it have clinical utility for pain medicine at the present time? A structured review

21 January 2018

1 reference

Pharmacogenomics: translating functional genomics into rational therapeutics

21 January 2018

1 reference

Ethical perspectives on pharmacogenomic profiling in the drug development process

21 January 2018

1 reference

Ethical considerations in clinical pharmacogenomics research

21 January 2018

1 reference

Ethical, legal, and social implications of genomic medicine

21 January 2018

1 reference

Genomic Priorities and Public Health

21 January 2018

1 reference

Using pharmacogenetics to improve drug safety and efficacy

21 January 2018

1 reference

Integrating pharmacogenetics into society: in search of a model

21 January 2018

1 reference

Translation of pharmacogenomics and pharmacogenetics: a regulatory perspective

21 January 2018

1 reference

Pharmacogenetics and Pharmacogenomics in Drug Development and Regulatory Decision Making: Report of the First FDA‐PWG‐PhRMA‐DruSafe Workshop

21 January 2018

1 reference

Pharmacogenomics in Drug Development and Regulatory Decision-making: the Genomic Data Submission (GDS) Proposal

21 January 2018

1 reference

Pharmacogenetic screening and therapeutic drugs

21 January 2018

1 reference

A systematic review of cost-effectiveness analyses of pharmacogenomic interventions

21 January 2018

1 reference

Cost of illness studies: what is good about them?

21 January 2018

1 reference

Evaluating the burden of disease and spending the research dollars of the National Institutes of Health.

21 January 2018

1 reference

Pharmacogenetics - five decades of therapeutic lessons from genetic diversity

21 January 2018

1 reference

Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms

21 January 2018

1 reference

Health care use and costs for children with attention-deficit/hyperactivity disorder: national estimates from the medical expenditure panel survey.

21 January 2018

1 reference

The economic burden of non-influenza-related viral respiratory tract infection in the United States

21 January 2018

1 reference

Lost Productive Time and Cost Due to Common Pain Conditions in the US Workforce

21 January 2018

1 reference

Indexing pharmacogenetic knowledge on the World Wide Web.

21 January 2018

1 reference

Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

21 January 2018

1 reference

Codeine intoxication associated with ultrarapid CYP2D6 metabolism

21 January 2018

1 reference

Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future

21 January 2018

1 reference

A vision for the future of genomics research

21 January 2018

1 reference

Moving towards individualized medicine with pharmacogenomics

21 January 2018

1 reference

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response

21 January 2018

1 reference

Will Genetics Revolutionize Medicine?

21 January 2018

1 reference

Getting ready for gene-based medicine

21 January 2018

1 reference

Regulatory perspectives on pharmacogenomics: a review of the literature on key issues faced by the United States Food and Drug Administration

31 March 2020

1 reference

Pharmacogenetic challenges for the health care system

31 March 2020

1 reference

Economic and regulatory considerations in pharmacogenomics for drug licensing and healthcare

31 March 2020

1 reference

Pharmacogenetics and the future of medical practice

31 March 2020

1 reference

Pharmacogenomics. FDA puts the brakes on Roche's gene array test

31 March 2020

1 reference

Cost-of-illness studies: a major headache?

31 March 2020

1 reference

31 March 2020

1 reference

Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base

31 March 2020

1 reference

Availability of pharmacogenomics-based prescribing information in drug package inserts for currently approved drugs

31 March 2020

1 reference

PharmGKB: the pharmacogenetics and pharmacogenomics knowledge base

31 March 2020

1 reference

Assessing the cost-effectiveness of pharmacogenomics

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRD1749

1 reference

12 August 2017

1 reference

PubMed ID

15915153